PRASAD H RAO

Allopathic & Osteopathic Physicians|Hospitalist CARTERSVILLE, GA NPI 1285656330

General Payments — all program years on this page

$2,989.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 167
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $397.79 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $397.7919

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $526.9334
2019 $702.6842
2020 $244.3214
2021 $294.6018
2022 $295.6616
2023 $527.0824
2024 $397.7919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077990014 Janssen Pharmaceuticals, Inc $23.01 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077990032 Janssen Pharmaceuticals, Inc $25.52 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077990066 Janssen Pharmaceuticals, Inc $17.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087304219 Novartis Pharmaceuticals Corporation $21.71 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105376620 ABBVIE INC. $24.74 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130890191 PFIZER INC. $23.29 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131133020 PFIZER INC. $19.82 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131223845 PFIZER INC. $17.38 03/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133838748 Gilead Sciences, Inc. $21.16 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133838750 Gilead Sciences, Inc. $22.53 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133838752 Gilead Sciences, Inc. $17.84 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133838754 Gilead Sciences, Inc. $15.93 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140158559 Inari Medical, Inc. $15.99 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143315658 UCB, Inc. $21.87 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143315663 UCB, Inc. $22.15 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143315668 UCB, Inc. $22.15 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153421565 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.72 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153464796 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.90 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153638034 Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.08 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.